Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malazdrewich, C.
Right arrow Articles by Maheswaran, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malazdrewich, C.
Right arrow Articles by Maheswaran, S. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Vet Pathol 38:297-310 (2001)
© 2001 American College of Veterinary Pathologists

Pulmonary Expression of Tumor Necrosis Factor Alpha, Interleukin-1 Beta, and Interleukin-8 in the Acute Phase of Bovine Pneumonic Pasteurellosis

C. Malazdrewich, T. R. Ames, M. S. Abrahamsen and S. K. Maheswaran

Departments of Clinical and Population Sciences (CM, TRA) and Veterinary PathoBiology (MSA, SKM), College of Veterinary Medicine, University of Minnesota, St. Paul, MN


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
Inflammatory cytokines are suspected to contribute to the pathogenesis of bovine pneumonic pasteurellosis (BPP) through neutrophil recruitment, leukocyte activation, and the induction of a broad array of soluble inflammatory mediators. An in vivo experimental model of BPP was used to characterize the pulmonary expression kinetics of tumor necrosis factor alpha (TNF{alpha}), interleukin-1 beta (IL-1ß), and interleukin-8 (IL-8) genes and proteins during the acute phase of disease development. Cytokine expression in bronchoalveolar lavage (BAL) fluid, BAL cells, and pneumonic lung parenchyma was quantitated by northern blot analysis, enzyme-linked immunosorbent assay (ELISA), and in situ hybridization at 2, 4, 8, 16, and 24 hours after endobronchial inoculation of Pasteurella (Mannheimia) haemolytica. Expression of TNF{alpha}, IL-1ß, and IL-8 was significantly increased in the airways and lung lesions of infected calves as compared with mock-infected controls. Although kinetic patterns varied, peak levels of cytokine mRNA occurred within 8 hours postinfection (PI), and peak cytokine concentrations occurred within 16 hours PI. In all samples, IL-8 was expressed to the greatest extent and TNF{alpha} was least expressed. Expression of TNF{alpha} was restricted to alveolar macrophages. Alveolar and interstitial macrophages produced IL-1ß and IL-8 in the first 4 hours; bronchial and bronchiolar epithelial cells were also significant sources of IL-8 during this period. By 8 hours PI, neutrophils were the dominant source of both IL-1ß and IL-8. These findings demonstrate a spatial and temporal association between pulmonary expression of inflammatory cytokines and acute lung pathology, supporting the hypothesis that cytokines contribute to inflammatory lung injury in BPP.

Key words: Cattle; chemokine; enzyme-linked immunosorbent assay; in situ hybridization; morphometric analysis; northern blot; pneumonia; proinflammatory cytokine.

Bovine pneumonic pasteurellosis (BPP), an acute fibrinous pleuropneumonia caused by Pasteurella (Mannheimia) haemolytica, is a common and economically important disease of North American cattle. One of the hallmark histopathologic features of BPP is extensive infiltration of the lungs by neutrophils. Neutrophil depletion prior to experimental infection with P. haemolytica protects calves from subsequent lung injury,32,43 indicating that this cell type is directly or indirectly responsible for most of the pulmonary pathology observed in the disease. The mechanisms by which neutrophils mediate lung pathology in BPP remain undefined but are likely to include oxidative injury and structural degradation due to extracellular release of reactive oxygen intermediates and proteolytic lysosomal enzymes.33 Recognition of the importance of neutrophils in disease pathogenesis prompted us and others to investigate specific factors governing their recruitment and activation within P. haemolytica-infected bovine lung.

The migration and activation of neutrophils in inflamed tissue are regulated by a complex network of interactions among cytokines, leukocytes, vascular endothelium, cellular adhesion molecules, and soluble chemotactic factors. The inflammatory cytokines tumor necrosis factor alpha (TNF{alpha}), interleukin-1 beta (IL-1ß), and interleukin-8 (IL-8) play a central role in the initiation and orchestration of these interactions. TNF{alpha} and IL-1ß are pleiotropic early response polypeptides secreted by monocytes and macrophages in response to microbial pathogens and other stimuli.20 IL-8, a potent chemotactic and activating factor for neutrophils, is a C-X-C chemokine secreted by a variety of immune and nonimmune cell types, including monocytes, macrophages, fibroblasts, epithelial cells, and neutrophils.3,18

Pulmonary overexpression of inflammatory cytokines is believed to contribute to the pathogenesis of several infectious and inflammatory lung diseases in humans, including adult respiratory distress syndrome,11,21 cystic fibrosis,5,17 and pneumoconiosis.40 This overexpression is also associated with lung pathology in animal models of influenza pneumonia,24 silicosis,12 and immune complex alveolitis.42 Among domestic species, TNF{alpha}, IL-1ß, and IL-8 are implicated in the pathogenesis of swine influenza,41 porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae,2,16 and Corynebacterium pseudotuberculosis-induced pyogranulomas in sheep.14

A growing body of circumstantial evidence implicates inflammatory cytokines in the pathogenesis of BPP, prompting speculation that it may be possible to treat or prevent the disease through pharmacologic modulation of cytokine expression. Heat-killed P. haemolytica and purified P. haemolytica lipopolysaccharide (LPS) and leukotoxin (Lkt) induce the expression of TNF{alpha}, IL-1ß, and IL-8 mRNA and proteins by bovine alveolar macrophages in vitro.19,22,23,36,44,46 In addition, BPP is associated with the pulmonary expression of TNF{alpha}, IL-1ß, and IL-8 in vivo.8,45 Because in these studies pulmonary cytokine expression was evaluated 2–4 days after inoculation with P. haemolytica, it is difficult to draw definitive conclusions regarding a causative role for cytokines in disease pathogenesis. A comprehensive understanding of inflammatory cytokine expression during earlier stages of disease development would permit a more accurate assessment of the role of cytokines in disease pathogenesis, and is a necessary prerequisite for the development of therapeutic strategies based upon cytokine inhibition or antagonism.

The objectives of this study were to 1) characterize the kinetics of pulmonary TNF{alpha}, IL-1ß, and IL-8 gene and protein expression in the first 24 hours of experimental BPP, 2) compare patterns of cytokine expression in airways with those in lung lesions, and 3) identify major cellular sources of these cytokines within affected lung. Northern analysis was used to quantitate the expression of cytokine mRNA in bronchoalveolar lavage (BAL) cells and diseased lung parenchyma. Immunoreactive cytokines in BAL fluid and lung tissue extracts were measured by enzyme-linked immunosorbent assay (ELISA). In situ hybridization was used to localize the expression of cytokine mRNA within lung tissues; numbers of positively stained cells were enumerated by quantitative morphometric techniques, and stained cells were identified by cell type on the basis of cell morphology and location.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Preparation of bacterial inoculum

Pasteurella (Mannheimia) haemolytica A1 strain 12296, a field isolate recovered from a yearling calf with fatal pneumonic pasteurellosis, was propagated in phenol red–free RPMI 1640 medium (BioWhittaker, Walkersville, MD) supplemented with 2 mM L-glutamine as previously described.1 Logarithmic phase cultures were diluted with additional medium to adjust the final concentration to 1 x 109 colony-forming units (cfu)/ml as determined by spectrophotometry.

Animals and induction of experimental disease

Eighteen healthy male Holstein calves between 4 and 7 weeks of age were purchased from the University of Minnesota Department of Animal Science. The calves were weaned at birth and raised in individual hutches and were free of detectable serum antibodies against P. haemolytica surface antigens and Lkt as determined by ELISA using previously described methods.34 Pneumonic pasteurellosis was induced in 15 calves using a well-characterized, reproducible experimental model developed in our laboratory.1 Calves were sedated with xylazine (0.1 mg/kg intravenously) and positioned in sternal recumbency for the passage of a sterile fiberoptic bronchoscope into the left caudal lung lobe. With the tip of the endoscope wedged in a large bronchus, 5 ml (5 x 109 cfu) of logarithmic phase P. haemolytica was deposited into the airway, followed by 30 ml of sterile LPS-free phosphate-buffered saline (PBS), pH 7.4. Groups of three infected calves, randomly selected on the basis of birth order, were euthanatized at each of the following times postinfection (PI): 2, 4, 8, 16, and 24 hours. At necropsy, focally extensive regions of hemorrhage, interlobular edema, and consolidation consistent with pneumonic pasteurellosis were present in the left caudal lung lobe of all inoculated calves. Bacteriologic cultures of pulmonary lesions yielded pure colonies of P. haemolytica. Three control calves received mock infections in which an equal volume of sterile culture medium was substituted for bacteria. These animals were euthanatized at 24 hours PI and exhibited no gross pulmonary pathology at necropsy.

BAL and lung tissues

BAL fluid was collected from the right caudal lung lobe of all calves immediately prior to infection or mock infection and from the left caudal lung lobe at necropsy. Using a sterile fiberoptic endoscope, 60 ml of LPS-free PBS was infused into a large bronchus and immediately retrieved by gentle suction. This process was repeated with three additional 60-ml aliquots of PBS. Samples were pooled and centrifuged for 10 minutes at 400 x g (4 C) to separate fluid and cellular components. The supernatant was centrifuged again for 30 minutes at 15,000 x g (4 C) and stored at -80 C for quantitation of cytokines and urea. BAL cells were washed once with LPS-free PBS and lysed in 4 M guanidinium isothiocyanate containing 8 mM sodium citrate, 0.5% sodium lauroyl sarcosinate, and 8% (v/v) ß-mercaptoethanol. Cell lysates were stored at -80 C for RNA extraction and northern blot analysis.

Nonlavaged lung tissues were collected from the left caudal lung lobe of all calves. Samples were taken from the margins of gross pneumonic lesions in infected calves and from grossly normal lung in control calves. Tissue samples for in situ hybridization were fixed in neutral buffered formalin for 24 hours, stored at -20 C in 70% ethanol for 12–24 hours, processed, and embedded in paraffin by standard methods. Tissues for RNA extraction and northern analysis were snap-frozen in liquid nitrogen, homogenized in lysis buffer (4 M guanidinium isothiocyanate, 0.5% sodium lauroyl sarcosinate, 8 mM sodium citrate, and 8% [v/v] ß-mercaptoethanol), and stored at -80 C. Tissue extracts were prepared by homogenizing 1 g of fresh lung tissue per 3 ml of PBS containing 0.05% Tween-20 and recovering the supernatant after centrifugation for 10 minutes at 15,000 x g (4 C). Extracts were stored at -80 C for quantitation of cytokines by ELISA.

Plasmids

Bovine TNF{alpha}, IL-1ß, and IL-8 cDNAs (488, 474, and 230 base pairs [bp] in length, respectively) were cloned and sequenced in our laboratory,19,44 ligated into pcDNA3 (Invitrogen, Carlsbad, CA), and transformed into Escherichia coli DH5{alpha}. A 1,250-bp human glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA in pBluescript KS+ (Stratagene, La Jolla, CA) was the generous gift of Dr. M. Murtaugh (University of Minnesota, St. Paul, MN). All plasmids were purified by alkaline lysis using a commercial kit (Qiagen, Valencia, CA) according to the manufacturer's instructions.

RNA extraction and northern blot analysis

All solutions were treated with 0.1% diethylpyrocarbonate (DEPC) and glassware was baked overnight at 350 C before use. Total cellular RNA was extracted from BAL cells and lung tissues using the acid guanidinium thiocyanate and phenol–chloroform extraction method.9 Ten micrograms of RNA from each sample was electrophoretically fractionated in a 1.2% agarose gel containing 6.5% formaldehyde, transferred to a neutral nylon membrane (Schleicher and Schuell, Keene, NH), and covalently linked to the membrane by ultraviolet illumination. Membranes were prehybridized at 45 C for 2 hours in solution containing 50% formamide, 5x saline sodium citrate (SSC), 5x Denhardt's solution, 1% sodium dodecyl sulfate (SDS), and 0.1 mg/ml yeast tRNA.

Gel-purified TNF{alpha}, IL-1ß, IL-8, and GAPDH cDNA plasmid inserts were labeled with [{alpha}-32P]dCTP by DNase/DNA polymerase I nick translation, and unincorporated [{alpha}-32P]dCTP was removed using Elutip-d affinity columns (Schleicher and Schuell). Labeled probe was added to prehybridization buffer at 2 x 106 cpm/ml, and membranes were hybridized overnight at 45 C. Blots were washed to a stringency of 0.1x SSC/0.1% SDS at 50 C. Autoradiographs were prepared by exposing membranes to Kodak X-OMAT AR x-ray film (Eastman Kodak, Rochester, NY) with an intensifying screen for 1–3 days at -80 C. Phosphor screen autoradiographs were prepared (Phosphorimager SF, Molecular Dynamics, Sunnyvale, CA), and relative levels of cytokine-specific mRNA were quantified by densitometric analysis using ImageQuant software (Molecular Dynamics). Data were normalized to the expression of GAPDH mRNA. For each cytokine, values for infected calves were presented relative to mean normalized expression in mock-infected control calves.

TNF{alpha} ELISA

A capture ELISA was developed to quantitate immunoreactive TNF{alpha} in BAL fluid and lung extracts. Mouse monoclonal antibody 2C4 ascites and rabbit anti-TNF{alpha} antiserum were generously provided by Dr. T. H. Elsasser (USDA-ARS, Beltsville, MD), and purified recombinant bovine (rb)TNF{alpha} for use as a standard was generously provided by Dr. Dale Godson (Veterinary Infectious Disease Organization, Saskatoon, SK, Canada). All samples, standards, and detection antibodies were diluted in PBS containing 10% (v/v) bovine serum albumin blocking concentrate (Kirkegaard & Perry, Gaithersburg, MD). Unless otherwise indicated, all reactions were conducted in a volume of 100 µl, and plates were incubated at 37 C for 1 hour on a platform shaker. After each step, plates were washed five times with PBS containing 0.01% Tween-20. Monoclonal antibody 2C4 ascites diluted 1:1,000 in coating buffer (15 mM sodium carbonate, 35 mM sodium bicarbonate, and 3 mM sodium azide, pH 9.6) was adsorbed to 96-well ELISA plates (Costar Corp., Cambridge, MA) overnight at room temperature. After blocking nonspecific protein binding sites, samples and standards were added to plates. Samples were assayed in duplicate at twofold dilutions from neat to 1:8. Rabbit anti-bovine TNF{alpha} antiserum diluted 1:2,000 in blocking buffer was used for primary detection of bound cytokine, followed by secondary detection with horseradish peroxidase (HRP)-labeled polyclonal goat anti-rabbit IgG (Kirkegaard & Perry) at a dilution of 1:6,000. The color substrate tetramethylbenzidine (Kirkegaard & Perry) was added, and plates were incubated for 10 minutes at room temperature. The reaction was stopped with 100 µl of 1 M phosphoric acid, and absorbance was measured at 450 nm. For each plate, a standard curve was constructed using duplicate threefold dilutions of rbTNF{alpha}. Sample dilutions yielding absorbance readings in the linear region of the standard curve were used to calculate cytokine concentrations by interpolation using SOFTmax PRO software (Molecular Devices, Sunnyvale, CA).

IL-1ß ELISA

A capture ELISA was developed to quantitate immunoreactive IL-1ß in BAL fluid and lung extracts. Mouse monoclonal antibody SA22 specific for bovine IL–1ß25 was produced from hybridoma CRL-2052 (American Type Culture Collection, Manassas, VA) and purified by standard methods.15 Purified rbIL-1ß for use as a standard was generously provided by Dr. Kathleen Heaney (Fort Dodge Animal Health, Princeton, NJ). Samples were assayed in duplicate at twofold dilutions from neat to 1:8. Methods were as for the TNF{alpha} ELISA with the following exceptions. All samples, standards, and detection antibodies were diluted in PBS containing 10% (v/v) milk blocking concentrate (Kirkegaard & Perry). Purified monoclonal antibody SA22 in coating buffer (5 µg/ml) was adsorbed to plates overnight at room temperature. Rabbit anti-ovine IL-1ß antiserum (Chemicon, Temecula, CA) diluted 1:1,000 was used for primary detection, and HRP-labeled goat anti-rabbit IgG diluted 1:4,000 was used for secondary detection. Color development was allowed to proceed for 30 minutes before the reaction was stopped with 1 M phosphoric acid, and absorbance was measured at 450 nm.

IL-8 ELISA

Purified rbIL-8 and mouse monoclonal antibody 170.13 specific for bovine IL-8 were produced and characterized in our laboratory. A cDNA encoding the mature bovine IL-8 protein19 was subcloned into the pET15b expression vector (Novagen, Madison, WI), transformed into E. coli BL21({lambda}DE3)pLysS cells (Novagen), and expressed according to the manufacturer's recommendations. Histidine-tagged rbIL-8 was expressed, affinity purified on a Ni2+-resin column (Novagen), and concentrated by dialysis against polyethylene glycol. Purified rbIL-8 was used to produce hybridomas and monoclonal antibodies by standard methods in collaboration with Immunochemistry Technologies (Bloomington, MN).15 Monoclonal antibody 170.13 (IgG1) recognized rbIL-8 and recombinant human IL-8 in western blots and neutralized the neutrophil chemotactic activity of rbIL-8 in vitro.

A capture ELISA was developed to quantitate immunoreactive IL-8 in BAL fluid and lung extracts. Methods were as for the TNF{alpha} ELISA with the following exceptions. Samples and standards were diluted in PBS containing 10% (v/v) milk blocking concentrate. Purified monoclonal antibody 170.13 in coating buffer (5 µg/ml) was adsorbed to plates overnight at room temperature. BAL fluids were assayed in duplicate at twofold dilutions from neat to 1:8, and lung extracts were assayed in duplicate at 10-fold dilutions from neat to 1:1,000. Rabbit anti-ovine IL-8 antiserum (Chemicon) diluted 1:4,000 in blocking buffer containing 5% normal mouse serum was used for primary detection, and HRP-labeled goat anti-rabbit IgG diluted 1:6,000 in blocking buffer was used for secondary detection. Color development was allowed to proceed for 20 minutes before the reaction was stopped with 1 M phosphoric acid, and absorbance was measured at 450 nm.

Correction for variable dilution of BAL samples

Urea was used as an endogenous marker of dilution to calculate the extent to which epithelial lining fluid (ELF) was diluted during the BAL procedure in each calf.26 Blood for quantitation of serum urea nitrogen was drawn from the jugular vein of all calves immediately prior to euthanasia. Urea concentration in serum and BAL fluid was determined by enzymatic methods using a commercial kit (Sigma, St. Louis, MO) according to the manufacturer's instructions. Measured cytokine concentrations in BAL fluid were corrected for dilution and expressed as cytokine concentration per milliliter of ELF.

In situ hybridization

All solutions were treated with 0.1% DEPC, and glassware was baked overnight at 350 C before use. Plasmids containing TNF{alpha}, IL-1ß, and IL-8 cDNA inserts were linearized by restriction digestion, and sense and antisense digoxigenin (DIG)-labeled RNA probes were synthesized by in vitro transcription using a commercial kit (Boehringer Mannheim, Indianapolis, IN) according to the manufacturer's instructions. Labeled probes were ethanol precipitated and dissolved in ultrapure water. Probe concentration was determined by dot blot hybridization and subsequent immunologic detection using components of the DIG Nucleic Acid Detection Kit (Boehringer Mannheim).

Sections of paraffin-embedded lung tissue (5 µm) were cut, transferred to Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA), deparaffinized in xylene, and rehydrated through a series of graded ethanol baths to ultrapure water. Except where otherwise indicated, steps preceding hybridization were carried out at room temperature, and slides were rinsed with ultrapure water between steps. Tissue sections were hydrolyzed in 0.2 N HCl for 20 minutes, incubated in 0.15 M triethanolamine (pH 7.4) for 15 minutes, and transferred to 0.3% (v/v) Triton-X in PBS for 5 minutes. Tissues were permeabilized with 25 µg/ml proteinase K (Boehringer Mannheim) for 20 minutes at 37 C, acetylated with 0.25% (v/v) acetic anhydride in 0.1 M triethanolamine (pH 8.0), and incubated in 2x SSC for 10 minutes at 70 C. Sections were then dehydrated through a series of graded ethanol baths, air dried, and covered with 60 µl of hybridization buffer (50% deionized formamide, 7% dextran sulfate, 1x Denhardt's solution, 0.6 M NaCl, 0.05% SDS, 20 mM HEPES, 1 mM ethylenediaminetetraacetic acid, 1 mg/ml poly[A], and 250 µg/ml yeast tRNA) containing 180 ng of DIG-labeled antisense riboprobe specific for TNF{alpha}, IL-1ß, or IL-8. Siliconized glass cover slips were applied and sealed with rubber cement, and hybridization was conducted overnight at 43 C. Negative control sections were hybridized with buffer containing an equal concentration of the corresponding sense riboprobe or with buffer containing no added riboprobe.

Nonspecifically bound riboprobe was removed by enzymatic digestion and stringency washes as follows: 2x SSC for 30 minutes at 42 C, 50% formamide/2x SSC for 20 minutes at 52 C, 25 µg/ml ribonuclease A (Sigma) in enzyme buffer (10 mM Tris-HCl, pH 8.0, 0.5 M NaCl) for 30 minutes at 37 C, 1x SSC for 15 minutes at 37 C, and 0.1x SSC for 15 minutes at 37 C. Tissue sections were blocked for 30 minutes with Tris-buffered saline (0.1 M Tris-HCl, pH 7.4, 0.15 M NaCl) containing 3% normal sheep serum and then covered with sheep anti-DIG/alkaline phosphatase conjugate (Boehringer Mannheim) diluted 1:500 in blocking buffer and incubated for 1 hour at room temperature. After washing three times for 5 minutes each in Tris-buffered saline (TBS), slides were incubated for 15 minutes in TBS containing 4 mM levamisole to inactivate endogenous alkaline phosphatases. The color substrates nitroblue tetrazolium and 5-bromo-4-chloro-indoyl phosphate were applied to sections, and slides were incubated in the dark for 18 hours at room temperature. After a final rinse in ultrapure water, tissues were counterstained with nuclear fast red (Vector Laboratories, Burlingame, CA) and mounted with aqueous medium.

Morphometric analysis

Cells staining positive for cytokine mRNA in lung tissue were quantified using a combination of light microscopy and digital image analysis. For each calf, images of a minimum of three microscopic fields from each of at least three tissue sections (a minimum of nine fields/animal) were electronically captured using an Eclipse E800 microscope (Nikon, Melville, NY) equipped with a CoolCam 2000 digital video camera (Cool Camera Company, Atlanta, GA). Nonoverlapping fields were selected at random along a line defining the long axis of the tissue section. Positively stained cells were identified by light microscopy. Image-Pro Plus image analysis software (Media Cybernetics, Silver Spring, MD) was used to mark and count stained cells in digital images and to calculate the surface area of tissue fields analyzed. Results were expressed as the number of positively staining cells per square millimeter of tissue.

Cells staining positive for cytokine mRNA in lung tissue were classified according to cell type. Fifty stained cells in each of at least three light microscopic fields per tissue section (three sections/animal) were identified by cell type on the basis of cell morphology and histologic location. Fields were selected as for morphometric analysis; additional nonoverlapping fields were examined as needed to type a minimum of 450 cells/animal. Data from all calves in a given group were combined, and results were expressed in terms of the percentage of total staining cells.

Statistical analysis

All values were expressed as the mean ± SEM. Data from all groups were analyzed using the Kruskal–Wallis test, and individual groups were compared with the Mann–Whitney U-test. Differences were considered significant when P < 0.05.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Kinetics of cytokine mRNA expression in BAL cells

Northern analysis was used to characterize inflammatory cytokine gene expression within airways during the first 24 hours of experimental pneumonic pasteurellosis. Steady-state levels of TNF{alpha}, IL-1ß, and IL-8 mRNA in BAL cells collected at 2, 4, 8, 16, and 24 hours PI were compared with those in cells from mock-infected control calves (Fig. 1). For all three cytokines, postinfection mRNA levels were significantly higher than those of controls (P < 0.05), and maximal levels occurred within 4 hours of disease onset. Peak levels of TNF{alpha} mRNA occurred at 2 hours PI, and peak levels of IL-1ß and IL-8 mRNA occurred at 4 hours PI. At maximum expression, levels of IL-1ß and IL-8 mRNA were roughly twofold greater than those of TNF{alpha} mRNA. Expression of TNF{alpha} and IL-1ß mRNA declined to control levels by 8 hours PI, but IL-8 mRNA levels were significantly increased throughout the 24-hour study period (P < 0.05). To rule out the possibility that experimental results were influenced by preexisting differences in levels of gene expression between the groups of calves euthanatized at various time points, preinfection BAL cells collected from the right lung of all calves were subjected to identical northern analysis. Results showed no significant differences in preinfection cytokine mRNA expression among groups (data not shown).



View larger version (33K):
[in this window]
[in a new window]
  		Fig. 1. Kinetics of TNF{alpha}, IL-1ß, and IL-8 mRNA expression in BAL cells from calves with acute pneumonic pasteurellosis. Inflammatory cytokine gene expression was quantitated by densitometric analysis of northern blots. For each cytokine, data were normalized to the expression of GAPDH mRNA and presented relative to mean normalized expression in BAL cells from mock-infected control calves. Values represent the mean ± SEM (n = 3). *P < 0.05 compared with mock-infected controls.

 
Kinetics of cytokine mRNA expression in pneumonic lung

Northern analysis was used to characterize inflammatory cytokine gene expression within pulmonary lesions of pneumonic pasteurellosis during the first 24 hours of disease. Steady-state levels of TNF{alpha}, IL-1ß, and IL-8 mRNA in lesional lung tissues collected at 2, 4, 8, 16, and 24 hours PI were compared with those in grossly normal lung tissues from mock-infected control calves (Fig. 2). For all three cytokines, postinfection mRNA levels were significantly higher than those of controls (P < 0.05), and peak levels occurred within 8 hours of disease onset. At maximum expression, levels of IL-1ß and IL-8 mRNA were roughly 5- and 60-fold greater, respectively, than those of TNF{alpha} mRNA. By 24 hours PI, mRNA for each of the cytokines had declined to control (TNF{alpha} and IL-1ß) or near-control (IL-8) values. To address the possibility that experimental results were influenced by differences in gene expression among the groups due to factors unrelated to P. haemolytica infection, tissues collected from the unaffected right lung of all calves at necropsy were subjected to identical northern analysis. Results showed no significant differences in cytokine mRNA levels among groups (data not shown).



View larger version (33K):
[in this window]
[in a new window]
  		Fig. 2. Kinetics of TNF{alpha}, IL-1ß, and IL-8 mRNA expression in the lungs of calves with acute pneumonic pasteurellosis. Inflammatory cytokine gene expression was quantitated by densitometric analysis of northern blots. For each cytokine, data were normalized to the expression of GAPDH mRNA and presented relative to mean normalized expression in lung tissues from mock-infected control calves. Values represent the mean ± SEM (n = 3). *P < 0.05 compared with mock-infected controls.

 
Although overall kinetic patterns in lung lesions were similar to those in BAL cells, some important differences were observed. Upregulation of TNF{alpha} mRNA was 10-fold greater in BAL cells than in lung tissue, suggesting that these cells constitute the major cellular source of TNF{alpha} in affected lungs. At 2 hours PI, the time at which TNF{alpha} mRNA levels were highest in both samples, BAL cells are comprised largely of alveolar macrophages.43 This finding provides indirect evidence that alveolar macrophages are important sources of TNF{alpha} in P. haemolytica-infected bovine lung. Similarly, upregulation of IL-1ß gene expression was fourfold greater in BAL cells than in lung lesions, suggesting that BAL cells are important sources of IL-1ß within affected lung. Because BAL cells consist largely of neutrophils at 4–8 hours PI,43 the period during which peak IL-1ß mRNA levels were observed, this finding provides indirect evidence that neutrophils are important pulmonary sources of IL-1ß in BPP. Upregulation of IL-8 mRNA was threefold greater in lung lesions than in BAL cells, suggesting that pulmonary cell types not present in BAL fluid produce significant amounts of IL-8.

Kinetics of cytokine secretion in ELF

ELISAs were used to characterize inflammatory cytokine secretion within airways. Concentrations of immunoreactive TNF{alpha}, IL-1ß, and IL-8 in BAL fluid collected prior to infection and at 2, 4, 8, 16, and 24 hours PI were compared with those in BAL fluid from mock-infected controls. Urea was used as an endogenous marker of dilution to calculate the extent to which ELF was diluted during BAL in each calf. Measured values were then corrected for dilution and expressed as cytokine concentration per milliliter of ELF (Fig. 3). We consider this the best practical method by which to control for variable dilution of ELF constituents during BAL. Samples collected prior to inoculation with P. haemolytica and those from mock-infected controls contained no detectable TNF{alpha}, IL-1ß, or IL-8. Concentrations of all three cytokines were significantly increased by 2 hours PI and remained elevated throughout the 24-hour study period (P < 0.05). Peak concentrations of TNF{alpha} (6.5 ± 0.4 ng/ml), IL-1ß (48.0 ± 11.8 ng/ml), and IL-8 (5.4 ± 1.3 µg/ml) occurred at 4, 8, and 16 hours PI, respectively.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 3. Kinetics of TNF{alpha}, IL-1ß, and IL-8 secretion in the airways of calves with acute pneumonic pasteurellosis. Immunoreactive cytokines in BAL fluid were quantitated by antigen-capture ELISA. Urea was used as an endogenous marker of dilution to calculate the extent to which ELF was diluted during the BAL procedure in each calf. Measured values were corrected for dilution and expressed as cytokine concentration per milliliter of ELF. Values represent the mean ± SEM (n = 3). *P < 0.05 compared with mock-infected controls.

 
Kinetics of cytokine expression in pneumonic lungs

ELISAs were used to characterize the expression of inflammatory cytokines within pulmonary lesions of pneumonic pasteurellosis. Concentrations of immunoreactive TNF{alpha}, IL-1ß, and IL-8 in extracts of pneumonic lung collected at 2, 4, 8, 16, and 24 hours PI were compared with those in extracts of grossly normal lung from mock-infected controls (Fig. 4). Control extracts contained 68.0 ± 6.0 ng/ml IL-8 but no detectable TNF{alpha} or IL-1ß. As in ELF, concentrations of all three cytokines were significantly increased in tissue extracts by 2 hours PI and remained elevated throughout the 24-hour study period (P < 0.05). Peak concentrations of TNF{alpha} (131 ± 18 pg/ml) occurred at 8 hours PI, and peak concentrations of IL-1ß (56.9 ± 6.5 ng/ml) and IL-8 (3.4 ± 0.6 µg/ml) occurred at 16 hours PI. Except that expression of TNF{alpha} and IL-1ß was more prolonged in lung extracts than in ELF, overall kinetic patterns were similar. Relative concentrations in the two samples varied among cytokines, however. Whereas maximal concentrations of IL-1ß and IL-8 were on roughly the same order of magnitude in either sample, TNF{alpha} concentrations were 50-fold higher in ELF than in lung extracts. This observation was consistent with the results of northern analysis and provides further evidence that TNF{alpha} expression in BPP occurs primarily within airways.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 4. Kinetics of TNF{alpha}, IL-1ß, and IL-8 expression in the lungs of calves with acute pneumonic pasteurellosis. Immunoreactive cytokines in extracts of lesional lung tissue were quantitated by antigen-capture ELISA. Values represent the mean ± SEM (n = 3). Extracts of mock-infected control lung tissue contained 68.0 ± 6.0 ng/ml IL-8 but no detectable TNF{alpha} or IL-1ß. *P < 0.05 compared with controls.

 
In situ hybridization analysis of pulmonary cytokine mRNA expression

In situ hybridization with nonradioactive DIG-labeled riboprobes was used to localize inflammatory cytokine mRNA in infected and mock-infected lung tissues. Cells staining positive for TNF{alpha}, IL-1ß, and IL-8 mRNA were enumerated by quantitative morphometric analysis using a combination of light microscopy and digital image analysis (Fig. 5). Tissue sections from mock-infected controls contained 2.6 ± 0.3 cells/mm2 staining positive for TNF{alpha} mRNA and no detectable staining for IL-1ß or IL-8 gene expression. In postinfection lung, the number of cells expressing mRNA specific for each of the cytokines was significantly increased throughout the 24 hour period following inoculation with P. haemolytica (P < 0.05). Peak numbers of cells expressing TNF{alpha} mRNA (15.9 ± 1.4 cells/mm2) occurred at 2 hours PI, and peak numbers of cells expressing mRNA specific for IL-1ß (640 ± 208 cells/mm2) and IL-8 (7,392 ± 2,519 cells/mm2) occurred at 8 hours PI. These data were consistent with the results of both northern analysis and ELISA and provide further evidence that IL-8 is expressed to the greatest extent within P. haemolytica-infected lung, whereas TNF{alpha} is least expressed.



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 5. Changes over time in the number of cells expressing TNF{alpha}, IL-1ß, and IL-8 mRNA in the lungs of calves with acute pneumonic pasteurellosis. Pulmonary expression of cytokine mRNA was localized by in situ hybridization. The number of positively staining cells per square millimeter of lung tissue was determined by quantitative morphometric analysis. Values represent the mean ± SEM (n = 3). Mock-infected control tissues contained 2.6 ± 0.3 cells/mm2 staining positive for TNF{alpha} mRNA and no detectable staining for IL-1ß or IL-8 mRNA. *P < 0.05 compared with controls.

 
In situ hybridization with the TNF{alpha} antisense riboprobe revealed that pulmonary expression of TNF{alpha} mRNA was restricted to alveolar macrophages in both infected and mock-infected lungs (Fig. 6). TNF{alpha} was the only cytokine for which mRNA-expressing cells were detected in control tissues. No staining was observed in lung tissues hybridized with the TNF{alpha} sense riboprobe (Fig. 7). Hybridization of tissues with the IL-1ß antisense probe showed that at 2 hours PI, expression of IL-1ß mRNA was localized to alveolar macrophages and cells within the alveolar septum, likely intravascular and/or interstitial macrophages (Fig. 8). Definitive identification of cell types at later time points was hindered by suboptimal tissue morphology, but comparison of serial sections routinely stained with hematoxylin and eosin confirmed that neutrophils within exudate in alveolar spaces and the lumina of bronchi and bronchioles became the dominant cellular source of IL-1ß mRNA within 4–8 hours of disease onset (Fig. 9). Hybridization of lung tissues with the IL-1ß sense riboprobe yielded no detectable staining (Fig. 10). At 2 and 4 hours PI, IL-8 mRNA was detected in alveolar macrophages, macrophages within the alveolar septum, bronchial epithelial cells, bronchiolar epithelial cells, and neutrophils (Fig. 11). At 8 hours PI and later time points, the majority of staining for IL-8 mRNA occurred in neutrophils within alveolar exudate and exudate in the lumina of bronchioles and bronchi (Fig. 12). Staining was also observed in fibroblasts within interlobular septa. No staining was observed in tissues hybridized with the IL-8 sense riboprobe (Fig. 13). A quantitative analysis of the cell types represented among cells staining positive for TNF{alpha}, IL-1ß, and IL-8 at each time point was performed. The results for IL-1ß and IL-8 mRNA are summarized in Fig. 14. Expression of TNF{alpha} mRNA was restricted to alveolar macrophages.



View larger version (34K):
[in this window]
[in a new window]
  		Fig. 6. Lung; P. haemolytica-inoculated calf, 2 hours PI. Blue-black cytoplasmic staining indicates that alveolar macrophages (arrows) express TNF{alpha} mRNA in the peracute phase of pneumonic pasteurellosis. In situ hybridization with antisense probe, nuclear fast red counterstain. Bar = 25 µm.
Fig. 7. Lung; P. haemolytica-inoculated calf, 2 hours PI. No staining is evident in tissues hybridized with TNF{alpha} sense probe. In situ hybridization, nuclear fast red counterstain. Bar = 25 µm.

 


View larger version (183K):
[in this window]
[in a new window]
  		Fig. 8. Lung; P. haemolytica-inoculated calf, 2 hours PI. Alveolar macrophages (arrows) and cells within the alveolar septum, likely intravascular macrophages, express IL-1ß mRNA in the peracute phase of pneumonic pasteurellosis. In situ hybridization with antisense probe, nuclear fast red counterstain. Bar = 25 µm.
Fig. 9. Lung; P. haemolytica-inoculated calf, 8 hours PI. Neutrophils within alveolar exudate express IL-1ß mRNA in the lesions of acute pneumonic pasteurellosis. In situ hybridization with antisense probe, nuclear fast red counterstain. Bar = 50 µm.
Fig. 10. Lung; P. haemolytica-inoculated calf, 8 hours PI. No staining is evident in pneumonic lung tissues hybridized with IL-1ß sense probe. In situ hybridization, nuclear fast red counterstain. Bar = 50 µm.
Fig. 11. Lung; P. haemolytica-inoculated calf, 4 hours PI. Bronchiolar epithelial cells (arrows) and neutrophils within alveolar exudate and the bronchiolar lumen express IL-8 mRNA in the peracute lesions of pneumonic pasteurellosis. In situ hybridization with antisense probe, nuclear fast red counterstain. Bar = 50 µm.
Fig. 12. Lung; P. haemolytica-inoculated calf, 8 hours PI. Extensive staining of neutrophils within alveolar exudate reflects widespread expression of IL-8 mRNA in the acute lesions of pneumonic pasteurellosis. In situ hybridization with antisense probe, nuclear fast red counterstain. Bar = 100 µm.
Fig. 13. Lung; P. haemolytica-inoculated calf, 8 hours PI. No staining is evident in pneumonic tissues hybridized with IL-8 sense probe. In situ hybridization, no counterstain. Bar = 50 µm.

 


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 14. Cell types expressing IL-1ß and IL-8 mRNA in the lungs of calves with pneumonic pasteurellosis. Pulmonary expression of cytokine mRNA was localized by in situ hybridization. Positively staining cells were identified by light microscopy on the basis of cell morphology and histologic location.

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
Recent investigations implicate inflammatory cytokines in the pathogenesis of BPP. In this study, early and sustained expression of TNF{alpha}, IL-1ß, and IL-8 mRNA and proteins was demonstrated within the airways and lung lesions of cattle experimentally infected with P. haemolytica. By contrast, samples collected from mock-infected control animals and the unaffected lung of infected cattle exhibited little or no such expression. These findings are consistent with earlier reports identifying an association between lung pathology and increased pulmonary expression of inflammatory cytokines in BPP.8,45 However, because the present study addresses the peracute and acute phases of disease development, it provides stronger evidence in support of a causative role for TNF{alpha}, IL-1ß, and IL-8 in disease pathogenesis. This study also extends previous work by characterizing the kinetics of pulmonary cytokine expression during the initial 24 hours of disease, comparing patterns of expression in airways with those in lung parenchyma, and identifying the major cellular sources of inflammatory cytokines within pneumonic lung.

The results obtained by northern analysis, ELISA, and in situ hybridization were closely correlated. Expression of TNF{alpha}, IL-1ß, and IL-8 in the airways and lung parenchyma of infected calves was significantly upregulated at both the gene and protein levels. In all samples, IL-8 mRNA and proteins were upregulated to the greatest extent and those for TNF{alpha} were upregulated the least. Northern blots and ELISAs suggested that TNF{alpha} gene and protein expression occurred predominantly within airways, and in situ hybridization studies confirmed that mRNA expression was localized to alveolar macrophages. Expression of IL-1ß and IL-8 genes and proteins, by contrast, was more generalized. Alveolar and interstitial macrophages were important early sources of both IL-1ß and IL-8, and bronchial and bronchiolar epithelial cells were significant sources of IL-8 in the first 4 hours PI. Neutrophils, however, became the dominant source of both IL-1ß and IL-8 within 4–8 hours of disease onset. These findings establish the existence of a spatial and temporal association between pulmonary expression of inflammatory cytokines and acute lung pathology, indirectly supporting the hypothesis that cytokines contribute to inflammatory lung injury in BPP.

In previous studies, pulmonary cytokine expression was measured between 2 and 4 days following endobronchial inoculation of P. haemolytica and changes over time were not addressed.8,45 In this study, we demonstrated that cytokine upregulation occurs much earlier in the course of disease development than was previously recognized. TNF{alpha}, IL-1ß, and IL-8 mRNA and proteins were significantly increased in all samples by 2 hours PI. Although kinetic patterns varied, peak levels of mRNA for all cytokines were achieved within 8 hours PI, and peak cytokine concentrations occurred within 16 hours PI. By 24 hours PI, mRNA specific for all three cytokines declined to near control values. Although cytokine concentrations in airways and lung lesions remained elevated throughout the study period, they were significantly decreased at 24 hours PI as compared with peak values achieved earlier. These observations suggest that TNF{alpha}, IL-1ß, and IL-8 may exert their greatest pathogenetic effects within 16 hours of disease onset.

The specific mechanisms, if any, by which inflammatory cytokines mediate lung injury in BPP await clarification. It is reasonable to assume, however, that their biologic effects in bovine lung parallel those recognized in other systems. In most mammalian models, TNF{alpha}, IL-1ß, and IL-8 are central components of a complex cytokine network that initiates, amplifies, and sustains the inflammatory response in tissue. Available evidence also supports the importance of this network in coordinating acute inflammatory responses within the lung.27,35 TNF{alpha} and IL-1ß are pleiotropic early response mediators that establish cytokine cascades through autocrine and paracrine activation of a broad array of cell types.20,31 They initiate neutrophil transmigration and activation by upregulating the expression of adhesion molecules on neutrophils and microvascular endothelium.7,38 Though not directly chemotactic for neutrophils, both TNF{alpha} and IL-1ß induce the secretion of IL-8, the most potent neutrophil chemotactic and activating factor, and other chemokines by a variety of cell types.4,27,35,37–39 In addition to their roles in neutrophil recruitment, TNF{alpha}, IL-1ß, and especially IL-8 promote neutrophil-mediated tissue injury by stimulating neutrophil degranulation and the extracellular release of arachidonic acid metabolites, toxic oxygen radicals, and proteolytic enzymes.6,10,13,28–30

Our findings indicate that IL-8 is the dominant inflammatory cytokine expressed within the lungs during the acute phase of BPP. Throughout the 24 hour period following inoculation of P. haemolytica, IL-8 was expressed in much greater quantities than either TNF{alpha} or IL-1ß. At 2 hours PI, the earliest time point studied, concentrations of IL-8 in ELF were already roughly 250- and 100-fold greater than those of TNF{alpha} and IL-1ß, respectively. In extracts of lesional lung parenchyma at the same time point, concentrations of IL-8 were roughly 17,000- and 100-fold greater than those of TNF{alpha} and IL-1ß, respectively. Previously, abundant pulmonary expression of IL-8 has been considered a downstream event that is dependent, at least in part, on the prior secretion of early response cytokines such as TNF{alpha} and IL-1ß.18,27,35 The findings reported here do not exclude the possibility that a similar cascade of interactions is a necessary prerequisite for IL-8 production in BPP, but do indicate that the critical events in that cascade must occur well before 2 hours PI. These observations, together with the results of the kinetic analyses, have at least two important implications for therapeutic strategies based upon modulation of inflammatory cytokines. First, pharmacologic agents that inhibit the synthesis of IL-8 or antagonize its biologic effects are likely to be more effective in the management of BPP than those targeting only TNF{alpha} or IL-1ß. Second, anti-cytokine agents may have to be administered very early in the course of disease, possibly even prior to colonization of the lung by P. haemolytica, to prevent or interrupt inflammatory lung injury.

This study demonstrated a correlation between early pulmonary expression of TNF{alpha}, IL-1ß, and IL-8 and the development of acute BPP, further substantiating a role for these mediators in disease pathogenesis. Inflammatory cytokines may therefore represent drug targets that could be pharmacologically modulated in the management of this important disease of cattle. The results reported here, however, suggest that such strategies may have to be implemented very early in the course of disease if they are to be effective. Because pulmonary expression of IL-8 was much greater than that of TNF{alpha} and IL-1ß at all time points studied, anti-cytokine agents targeting this mediator may be most useful in the prevention and treatment of BPP.


   Acknowledgments
 
We thank Dr. T. Elsasser and the USDA for providing anti-TNF{alpha} antibodies, Dr. K. Heaney and Fort Dodge Animal Health for providing recombinant IL-1ß, Dr. D. Godson and VIDO for providing recombinant TNF{alpha}, and Dr. M. Murtaugh for providing a human GAPDH cDNA. In addition, we are grateful to P. Ward, V. Lappi, and Dr. R. LaFleur for technical assistance. This research was supported by USDA-NRI competitive grant 95-37204-1963 and AVMA Foundation research grant 95-06.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ames TR, Markham RJF, Opuda-Asibo J, Leininger JR, Maheswaran SK: Pulmonary response to intratracheal challenge with Pasteurella haemolytica and Pasteurella multocida. Can J Comp Med 49:395-400, 1985[Medline]
  2. Baarsch MJ, Scamurra RW, Burger K, Foss DL, Maheswaran SK, Murtaugh MP: Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect Immun 63:3587-3594, 1995[Abstract]
  3. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989
  4. Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van Der Woude FJ: Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol 118:298-303, 1999[CrossRef][Medline]
  5. Bonfield TL, Konstan MW, Berger M: Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104:72-78, 1999[CrossRef][Medline]
  6. Brandt E, Petersen F, Flad HD: Recombinant tumor necrosis factor-{alpha} potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J Immunol 149:1356-1364, 1992[Abstract]
  7. Butcher EC: Leukocyte–endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991[CrossRef][Medline]
  8. Caswell JL, Middleton DM, Sorden SD, Gordon JR: Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis. Vet Pathol 35:124-131, 1998[Abstract]
  9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162:156-159, 1987[Medline]
  10. DiPersio JF, Billing P, Williams R, Gasson JC: Human granulocyte–macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis. J Immunol 140:4315-4322, 1988[Abstract]
  11. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647, 1993[CrossRef][Medline]
  12. Driscoll KE, Lindenschmidt RC, Maurer JK, Higgins JM, Ridder G: Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. Am J Respir Cell Mol Biol 2:381-390, 1990
  13. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA: Different priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 62:2195-2201, 1994[Abstract/Free Full Text]
  14. Ellis JA, Campos M, Snyder M, Chelak B, Haines DM: Local production of tumor necrosis factor-{alpha} in corynebacterial pulmonary lesions in sheep. Vet Pathol 32:68-71, 1995[Abstract]
  15. Harlow E, Lane D: Antibodies: A Laboratory Manual. pp 245-318, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1988
  16. Huang H, Potter AA, Campos M, Leighton FA, Willson PJ, Haines DM, Yates WDG: Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: roles of proinflammatory cytokines. Can J Vet Res 63:69-78, 1999[Medline]
  17. Konstan MW, Berger M: Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 24:137-142, 1997[CrossRef][Medline]
  18. Kunkel SL, Standiford T, Kasahara K, Strieter RM: Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 17:17-23, 1991[Medline]
  19. LaFleur RL, Abrahamsen MS, Maheswaran SK: The biphasic mRNA expression pattern of bovine interleukin-8 in Pasteurella haemolytica lipopolysaccharide-stimulated alveolar macrophages is primarily due to tumor necrosis factor alpha. Infect Immun 66:4087-4092, 1998[Abstract/Free Full Text]
  20. Larrick JW, Kunkel SL: The role of tumor necrosis factor and interleukin-1 in the immunoinflammatory response. Pharm Res 5:129-139, 1988[CrossRef][Medline]
  21. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GAW: Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712-714, 1989[CrossRef][Medline]
  22. Morsey MA, Popowych Y, Kowalski J, Gerlach G, Godson D, Campos M, Babiuk L: Molecular cloning and expression of bovine interleukin-8. Microb Pathog 20:203-212, 1996[CrossRef][Medline]
  23. Morsey MA, Van-Kessel AG, Mori Y, Popowych Y, Godson D, Campos M, Babiuk LA: Cytokine profiles following interaction between bovine alveolar macrophages and Pasteurella haemolytica. Microb Pathog 26:325-331, 1999[CrossRef][Medline]
  24. Peper RL, Van Campen H: Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 19:175-183, 1995[CrossRef][Medline]
  25. Reddy DN, Chitko-McKown CG, Reddy PG, Minocha HC, Blecha F: Isolation and characterization of monoclonal antibodies to recombinant bovine interleukin-1ß. Vet Immunol Immunopathol 36:17-29, 1993[CrossRef][Medline]
  26. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG: Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 60:532-538, 1986[Abstract/Free Full Text]
  27. Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Strieter RM: Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 5:493-501, 1991
  28. Sample AK, Czuprynski CJ: Bovine neutrophil chemiluminescence is preferentially stimulated by homologous IL-1, but inhibited by the human IL-1 receptor antagonist. Vet Immunol Immunopathol 41:165-172, 1994[CrossRef][Medline]
  29. Schroder JM: The monocyte-derived neutrophil activating peptide (NAP/interleukin-8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 170:847-863, 1989[Abstract/Free Full Text]
  30. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA: Activation of human polymorphonuclear neutrophil functions by interferon-{gamma} and tumor necrosis factors. J Immunol 135:2069-2073, 1985[Abstract]
  31. Sherry B, Cerami A: Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of the inflammatory responses. J Cell Biol 107:1269-1277, 1988[Free Full Text]
  32. Slocombe RF, Malark J, Ingersoll R, Derksen FJ, Robinson NE: Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am J Vet Res 46:2253-2258, 1985[Medline]
  33. Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 56:672-686, 1994[Abstract]
  34. Srinand S, Hsuan SL, Yoo HS, Maheswaran SK, Ames TR, Werdin RE: Comparative evaluation of antibodies induced by commercial Pasteurella haemolytica vaccines using solid phase immunoassays. Vet Microbiol 49:181-195, 1996[CrossRef][Medline]
  35. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, Westwick J, Strieter RM: Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 86:1945-1953, 1990
  36. Stevens P, Czuprynski C: Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccharide. Can J Vet Res 59:110-117, 1995[Medline]
  37. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M, Kunkel SL: Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-{alpha}, lipopolysaccharide, and interleukin-1ß. Am J Respir Cell Mol Biol 2:321-326, 1990
  38. Strieter RM, Kunkel SL: Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Invest Med 42:640-651, 1994[Medline]
  39. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF{alpha}, LPS, and IL-1ß. Science 243:1467-1469, 1989[Abstract/Free Full Text]
  40. Vanhée D, Gosset P, Marquette CH, Wallaert B, Lafitte JJ, Gosselin B, Voisin C, Tonnel AB: Secretion and mRNA expression of TNF{alpha} and IL-6 in the lungs of pneumoconiosis patients. Am J Respir Crit Care Med 152:298-306, 1995[Abstract]
  41. Van Reeth K, Labarque G, Nauwynck H, Pensaert M: Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity. Res Vet Sci 67:47-52, 1999[CrossRef][Medline]
  42. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, Ward P: Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 84:1873-1882, 1989
  43. Weiss DJ, Bauer MC, Whiteley LO, Maheswaran SK, Ames TR: Changes in blood and bronchoalveolar lavage fluid components in calves with experimentally induced pneumonic pasteurellosis. Am J Vet Res 52:337-344, 1991[Medline]
  44. Yoo HS, Maheswaran SK, Lin G, Townsend EL, Ames TR: Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide. Infect Immun 63:381-388, 1995[Abstract]
  45. Yoo HS, Maheswaran SK, Srinand S, Ames TR, Suresh M: Increased tumor necrosis factor-{alpha} and interleukin-1ß expression in the lungs of calves with experimental pneumonic pasteurellosis. Vet Immunol Immunopathol 49:15-28, 1995[CrossRef][Medline]
  46. Yoo HS, Rajagopal BS, Maheswaran SK, Ames TR: Purified Pasteurella haemolytica leukotoxin induces expression of inflammatory cytokines from bovine alveolar macrophages. Microb Pathog 18:237-252, 1995[CrossRef][Medline]
Request reprints from Dr. S. K. Maheswaran, Department of Veterinary PathoBiology, 205 Veterinary Sciences, 1971 Commonwealth Avenue, University of Minnesota, St. Paul, MN 55108 (USA). Email: mahes001{at}tc.umn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
A. E. Starr, T. Dan, K. Minhas, P. E. Shewen, and B. L. Coomber
Potential Involvement of Gelatinases and Their Inhibitors in Mannheimia haemolytica Pneumonia in Cattle
Infect. Immun., August 1, 2004; 72(8): 4393 - 4400.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. L. Booth, K. M. Coggeshall, B. E. Gordon, and J. P. Metcalf
Adenovirus Type 7 Induces Interleukin-8 in a Lung Slice Model and Requires Activation of Erk
J. Virol., April 15, 2004; 78(8): 4156 - 4164.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. Leite, S. O'Brien, M. J. Sylte, T. Page, D. Atapattu, and C. J. Czuprynski
Inflammatory Cytokines Enhance the Interaction of Mannheimia haemolytica Leukotoxin with Bovine Peripheral Blood Neutrophils In Vitro
Infect. Immun., August 1, 2002; 70(8): 4336 - 4343.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malazdrewich, C.
Right arrow Articles by Maheswaran, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malazdrewich, C.
Right arrow Articles by Maheswaran, S. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS